SCHEMBL5028996

SCHEMBL5028996

CSc1ccc(Nc2[nH]c(=O)c(Cl)cc2C(=O)NCOCC(C)O)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
MAP2K2 P36507 1/20 0.36
MAP2K1 Q02750 1/20 0.36
KCNH2 Q12809 1/20 0.35
KMT2A Q03164 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
MEN1 O00255 1/20 0.35
CYP2D6 P10635 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPT P10636 6/20 0.33
HPGD P15428 5/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 3/20 0.33
ALDH1A1 P00352 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14919911 0.92 MAP2K1 (0.38) HSD17B10TSHRHTTMAP2K2MAP2K1
SCHEMBL5035609 0.88 KCNH2 (0.41) MAP2K2MAP2K1KCNH2
SCHEMBL5028992 0.83 KCNH2 (0.37) HSD17B10TSHRHTTMAP2K2MAP2K1
SCHEMBL5029005 0.80 MAP2K1 (0.40) MAP2K2MAP2K1KMT2AMEN1MAPT
SCHEMBL5031223 0.79 MAP2K1 (0.42) MAP2K2MAP2K1KCNH2
SCHEMBL5031302 0.76 MAP2K1 (0.35) MAP2K2MAP2K1KCNH2CYP1A2SMN1; SMN2
SCHEMBL5029051 0.75 MAP2K1 (0.40) MAP2K2MAP2K1KMT2AMEN1MAPT
SCHEMBL14920264 0.74 MAP2K2 (0.38) MAP2K2MAP2K1KCNH2HPGDGAA
SCHEMBL13723742 0.74 MAP2K2 (0.38) MAP2K2MAP2K1KCNH2HPGDGAA
SCHEMBL5028995 0.71 MAP2K2 (0.39) MAP2K2MAP2K1KCNH2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1922307-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF Array Biopharma, Inc. (US) 2008-05-21 EP claimed
WO-2007044084-A2 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2007-04-19 WO claimed